Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01467466 · ClinicalTrials.gov registry record · Phase 3
Prevention of Serious Adverse Events Following Angiography
A Phase 3 study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 3
- Development phase
- 5,177
- Enrollment target
NCT01467466: Completed Phase 3 study, sponsored by VA Office of Research and Development.
NCT01467466 is a Phase 3 study that has completed, run by VA Office of Research and Development. The registered enrollment target is 5,177 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01467466, a Phase 3 study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 5,177 participants
- Enrollment target
Study Summary
The purpose of this research study is to compare the effectiveness of intravenous isotonic sodium bicarbonate with intravenous isotonic sodium chloride and oral N-acetylcysteine (NAC) with oral placebo for the prevention of serious adverse outcomes following angiographic procedures in high-risk patients.
Interventions
- DRUG Placebo
- DRUG N-acetylcysteine
- DRUG IV isotonic saline
- DRUG IV isotonic bicarbonate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,177 participants |
| Start Date | 2013-10-07 |
| Est. Completion | 2017-10-17 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01467466
The ClinicalTrials.gov registry entry for NCT01467466 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 5,177 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT01467466 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01467466 about?
NCT01467466 is a clinical study titled "Prevention of Serious Adverse Events Following Angiography". The purpose of this research study is to compare the effectiveness of intravenous isotonic sodium bicarbonate with intravenous isotonic sodium chloride and oral N-acetylcysteine (NAC) with oral placebo for the prevention of serious adverse outcomes following angiographic procedures in high-risk pati...
What is the current status of trial NCT01467466?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 5,177 participants. The study started on 2013-10-07. Estimated completion is 2017-10-17.
What interventions are being tested in trial NCT01467466?
The interventions under investigation include: Placebo (DRUG), N-acetylcysteine (DRUG), IV isotonic saline (DRUG), IV isotonic bicarbonate (DRUG).
Who is sponsoring clinical trial NCT01467466?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.